News

Search:

Panel Starts Investigation of India's Drug Regulatory Authority

1 Likes

India’s regulatory authority, the Central Drugs Standard Control Organization, has not had a particularly good start to 2012. Accounts of corruption and incompetence have been echoed in numerous Read More...

Tags:

Blasts

CDSCO

DCGI

India

Investigation

Panel

Parliament

Regulatory

report

As India Moves to Investigate Claims of Collusion, US Could Increase Scrutiny

0 Likes

Fallout from a report by the Indian Parliament alleging widespread collusion and ineffectiveness at India’s Central Drugs Standard Control Organization (CDSCO) continues, as the Indian government has Read More...

Tags:

Blasts

CDSCO

DCGI

DOJ

India

Investigation

Parliament

Regulatory

report

Scrutiny

Scathing Parliamentary Report Blasts India's Drug Regulatory Authority

1 Likes

A parliamentary report authored by India’s Standing Committee on Health and Family Welfare (SCHFW) is blasting the country’s Central Drugs Standard Control Organisation (CDSCO), India’s drug Read More...

Tags:

Blasts

CDSCO

DCGI

India

Parliament

Regulatory

report

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

Public Warms to FDA in Recent Gallup Poll 28 May 2013
FDA Finalizes Changes to Orphan Drug Regulation, With Emphasis on Clarifying Existing Policies 11 June 2013
Warning Letter to Company Cites Low Supplies of Toilet Paper 15 May 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013
Interview: FDA's UDI Architect Jay Crowley on the Agency's Approach to UDI and Pending Changes 2 May 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New Legislation Seeks Creation of Provisional Approval Pathway for New Drugs 23 May 2013
New FDA Draft Guidance Aims to Clarify Compassionate Use Process 9 May 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

Panel Starts Investigation of India's Drug Regulatory Authority

As India Moves to Investigate Claims of Collusion, US Could Increase Scrutiny

Scathing Parliamentary Report Blasts India's Drug Regulatory Authority

Get RF Today